Showing 8601-8610 of 20878 results for "".
Common Management of Foot Problems
https://reachmd.com/programs/clinicians-roundtable/common-management-of-foot-problems/7094/In Family Medicine, treating foot conditions is common. Today's interview is focused on the diagnosis and treatment of 5 common foot diagnoses, including Onychomycosis, Ingrown Toenails, Bunions, Diabetic Foot Care and Plantar Fasciitis. In this segment, host Dr. Jen Caudle speaks with guest Dr. MaaApples or Apple Pie: Helping Patients Make Healthy Changes
https://reachmd.com/programs/diabetes-discourse/apples-or-apple-pie-helping-patients-make-healthy-changes/5105/According to the National Institutes of Health, 85% of physicians state they are not effective in helping patients make healthy dietary changes. What are the obstacles for our healthcare professionals treating patients with diabetes? Join host Dr. Steven Edelman and his guest, best-selling author anManaging Chronic Diseases With Therapeutic Lifestyle Programs
https://reachmd.com/programs/clinicians-roundtable/managing-chronic-diseases-with-therapeutic-lifestyle-programs/4155/Scientific evidence shows that therapeutic lifestyle programs are the most cost effective programs to prevent, improve, or cure chronic diseases such as diabetes. Host Dr. Larry Kaskel discusses with Mike Katke, co-founder of Metagenics, Inc., the elements of a therapeutic lifestyle program and theClosing the Loop: Progress on the Artificial Pancreas Project
https://reachmd.com/programs/diabetes-discourse/closing-the-loop-progress-on-the-artificial-pancreas-project/5757/The Artificial Pancreas Project under the auspices of the Juvenile Diabetes Research Foundation is making strides towards closing the loop with improvements in communication between glucose sensors and external insulin pumps. What progress has been made in closing the loop in the development of theThe Latest Targets of Lipid Therapy
https://reachmd.com/programs/lipid-luminations/the-latest-targets-of-lipid-therapy/3182/Host Dr. Larry Kaskel welcomes Dr. Alan Brown, medical director of the Midwest Heart Disease Prevention Center in Naperville, Illinois, to discuss targets of lipid therapy. What are the calculated risk assessments for major cardiovascular events among patients with coronary disease, diabetes and othHeart Disease in the United States: Past, Present, and Future Trends
https://reachmd.com/programs/lipid-luminations/heart-disease-in-the-united-states-past-present-and-future-trends/5586/Cardiologists are proud of the general reduction of cardiovascular disease and death over the past 20 years, but there is still significant concern about the epidemic of obesity and diabetes on the future of cardiovascular disease. Dr. Tom Allison, consultant in cardiovascular disease and internal mGLP-1s: Educating Patients on Common Ocular Complications
https://reachmd.com/programs/modern-optometry/glp-1s-educating-patients-on-common-ocular-complications/56817/In this episode, Joseph J. Allen, OD, FAAO, Dipl ABO, covers the ocular side effects associated with GLP-1s, initially prescribed for diabetes management and now gaining popularity for their weight loss control capabilities. Dr. Allen emphasizes the importance of a baseline eye examination and documReducing Endometrial Cancer Risk: Targeting Modifiable Risk Factors
https://reachmd.com/programs/project-oncology/endometrial-cancer-modifiable-risk-factors/39930/Endometrial cancer is closely tied to modifiable risk factors such as obesity, diabetes, hypertension, and insulin resistance—all components of a chronic inflammatory state that heightens cancer susceptibility. Dr. Brian Slomovitz discusses how lifestyle interventions and emerging therapies may reduAre We Close to Development of an Artificial Pancreas?
https://reachmd.com/programs/diabetes-discourse/are-we-close-to-development-of-an-artificial-pancreas/5009/The developing artificial pancreas carries tremendous potential for the treatment of diabetes. What is research telling us about the various steps to the implementation of the system? Join host Dr. Steven Edelman and his guest, pediatric endocrinologist and professor of medicine at Stanford UniversRetinal Vein Occlusion as a Marker of Systemic Risk
https://reachmd.com/programs/eye-on-ocular-health/retinal-vein-occlusion-as-a-marker-of-systemic-risk/54492/Retinal vein occlusion is more than an ocular event—it's often a warning sign of underlying systemic vascular disease, including hypertension, diabetes, and dyslipidemia. Join Dr. Ashkan Abbey as he discusses how retinal vein occlusion should prompt a broader medical evaluation to help reduce the ri